Infections after hematopoietic stem cell transplantation: Difference between revisions
From IDWiki
m (→: typo) |
m (→: linkified) |
||
Line 12: | Line 12: | ||
|- |
|- |
||
| '''Early post-engraftment'''<br/>to day 100 |
| '''Early post-engraftment'''<br/>to day 100 |
||
| |
| Immunosuppressing meds, acute GVHD, central lines |
||
| GPCs, [[encapsulated bacteria]], [[Listeria]], [[Salmonella]], [[Nocardia]] |
| GPCs, [[encapsulated bacteria]], [[Listeria]], [[Salmonella]], [[Nocardia]] |
||
| [[HSV]], [[CMV]], [[HHV-6]], [[adenovirus]], resp/enteric viruses |
| [[HSV]], [[CMV]], [[HHV-6]], [[adenovirus]], resp/enteric viruses |
||
Line 20: | Line 20: | ||
| '''Mid post-engraftment'''<br/>to 1 year |
| '''Mid post-engraftment'''<br/>to 1 year |
||
| Immunosuppressing meds, chronic GVHD |
| Immunosuppressing meds, chronic GVHD |
||
| Encapsulated bacteria, Listeria, Salmonella, Nocardia |
| [[Encapsulated bacteria]], [[Listeria]], [[Salmonella]], [[Nocardia]] |
||
| [[VZV]], [[EBV]] (and PTLD), CMV, |
| [[VZV]], [[EBV]] (and [[PTLD]]), [[CMV]], respiratory/enteric viruses |
||
| [[Aspergillus]], other [[molds]], [[PJP]] |
| [[Aspergillus]], other [[molds]], [[PJP]] |
||
| |
| |
||
Line 28: | Line 28: | ||
| Immuneosuppresing meds, chronic GVHD |
| Immuneosuppresing meds, chronic GVHD |
||
| [[Encapsulated bacteria]], [[Listeria]], [[Salmonella]], [[Nocardia]] |
| [[Encapsulated bacteria]], [[Listeria]], [[Salmonella]], [[Nocardia]] |
||
| [[VZV]], [[CMV]], |
| [[VZV]], [[CMV]], respiratory/enteric viruses |
||
| |
| |
||
| |
| |
Revision as of 00:50, 13 May 2020
Timeline of Infections
Time | Risk factors | Bacteria | Viruses | Fungi | Parasites |
---|---|---|---|---|---|
Pre-engraftment day 0 to 30 |
Neutropenia, mucositis, and central lines | GPCs and GNBs | BK virus, HSV, and resp/enteric viruses | Candida and Aspergillus | Strongyloides |
Early post-engraftment to day 100 |
Immunosuppressing meds, acute GVHD, central lines | GPCs, encapsulated bacteria, Listeria, Salmonella, Nocardia | HSV, CMV, HHV-6, adenovirus, resp/enteric viruses | Aspergillus, other molds, PJP | Stronyloides, Toxoplasma |
Mid post-engraftment to 1 year |
Immunosuppressing meds, chronic GVHD | Encapsulated bacteria, Listeria, Salmonella, Nocardia | VZV, EBV (and PTLD), CMV, respiratory/enteric viruses | Aspergillus, other molds, PJP | |
Late post-engraftment after 1 year |
Immuneosuppresing meds, chronic GVHD | Encapsulated bacteria, Listeria, Salmonella, Nocardia | VZV, CMV, respiratory/enteric viruses |
Further Reading
- Life-threatening Infection in Transplant Recipients. Crit Care Clin. 2013 Oct;29(4):953-73. doi: 10.1016/j.ccc.2013.06.012